High-dose First-line Treatment Regimen for Recurrent Rifampicin-susceptible Tuberculosis. Decroo T, de Jong BC, Piubello A, Souleymane MB, et al. Am J Respir Crit Care Med 2020 Mar 4. doi: 10.1164/rccm.202001-0201.

Read + Share

Amedeo Smart

Independent Medical Education

Decroo T, de Jong BC, Piubello A, Souleymane MB, et al. High-dose First-line Treatment Regimen for Recurrent Rifampicin-susceptible Tuberculosis. Am J Respir Crit Care Med 2020 Mar 4. doi: 10.1164/rccm.202001-0201.
PMID: 32130864